Event JSON
{
"id": "ff0bcb4afdb0c8a841492b33f8f77a735497bdc1d1a1942cb127b3b528b4bd7a",
"pubkey": "024c71f09ab1973b6f6765038fc8c6a009099fb63c084aacf118a3201cd0b1b0",
"created_at": 1730401239,
"kind": 1,
"tags": [
[
"p",
"e1cf6050d654f800abe3c51cb488b3dec85bb035800c5d6d00c8899ad2921282",
"wss://relay.mostr.pub"
],
[
"p",
"f2970532951a2713b06c1df7d816f72e9af558e678ee6b02dc357cd6dafc85b3",
"wss://relay.mostr.pub"
],
[
"proxy",
"https://flipboard.com/users/AssociatedPress/statuses/yZ-rjTBESieBib49dNJWCw:a:3199720",
"activitypub"
]
],
"content": "A promising schizophrenia drug showed mixed results. What does that mean for patients?\nhttps://apnews.com/article/schizophrenia-cobenfy-bristol-myers-squibb-37d550fb7c4ed71e4fcea85ded4ae5a9?utm_source=flipboard\u0026utm_medium=activitypub \n\nPosted into Business and Finance nostr:npub1u88kq5xk2nuqp2lrc5wtfz9nmmy9hvp4sqx96mgqezye455jz2pqaurdls",
"sig": "c99d6003689496a4b6ac4bcd434f073cf6265b905f396d3d28a54133141cad8dbbc5a7fbdfde039dce483810c208061215a5526cb811bebafc20e0d9f5f24309"
}